Susan Secore

发表

Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.

R. Rustandi, J. Heinrichs, D. Thiriot, 2016, Vaccine.

Development and Optimization of a Novel Assay To Measure Neutralizing Antibodies against Clostridium difficile Toxins

J. Bodmer, J. Heinrichs, M. Horton, 2013, Clinical and Vaccine Immunology.

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera

Amy S. Espeseth, A. Espeseth, M. Feinberg, 2022, eBioMedicine.

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.

Charles Y. Tan, A. Finnefrock, Victoria Towne, 2010, Human antibodies.

Development and Optimization of a High-Throughput Assay To Measure Neutralizing Antibodies against Clostridium difficile Binary Toxin

Colleen E. Price, J. Heinrichs, M. Horton, 2014, Clinical and Vaccine Immunology.

Development and Optimization of a High-Throughput Assay To Measure Neutralizing Antibodies against Clostridium difﬁcile Binary Toxin

Colleen E. Price, J. Heinrichs, M. Horton, 2014 .

Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant.

R. Rustandi, J. Heinrichs, G. Dornadula, 2015, Vaccine.

Split-Dose Administration Enhances Immune Responses Elicited by a mRNA/Lipid Nanoparticle Vaccine Expressing Respiratory Syncytial Virus F Protein.

Lauren A Austin, Marian E. Gindy, A. Bett, 2022, Molecular pharmaceutics.

A fully human monoclonal antibody to Staphylococcu saureu siro nregulate dsurface determinant B (IsdB) with functional activity i nvitr oan di nvivo

Charles Y. Tan, A. Finnefrock, Victoria Towne, 2010 .

A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

Charles Y. Tan, W. Mcclements, K. Jansen, 2006, Infection and Immunity.

Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains

R. Rustandi, J. Bodmer, J. Heinrichs, 2017, PloS one.

Selection and Characterization of Murine Monoclonal Antibodies to Staphylococcus aureus Iron-Regulated Surface Determinant B with Functional Activity In Vitro and In Vivo

A. Finnefrock, Qinjian Zhao, Victoria Towne, 2009, Clinical and Vaccine Immunology.

Kartsonis and Mark T. Esser Serologic Assay to Quantify Human

L. Cope, M. Esser, A. Anderson, 2009 .

Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.

J. Bodmer, J. Heinrichs, J. Joyce, 2014, Vaccine.

Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

A. Therien, P. Orth, L. Hernandez, 2014, The Journal of Biological Chemistry.

An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile

Alexander J. Probst, J. Warrington, Justin Kuczynski, 2014, The ISME Journal.

Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab.

D. Lacy, A. Therien, Xinwei Sher, 2017, Journal of molecular biology.

Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection.

J. Bodmer, J. Heinrichs, J. Joyce, 2016, Methods in molecular biology.

Serologic Assay To Quantify Human Immunoglobulin G Antibodies to the Staphylococcus aureus Iron Surface Determinant B Antigen

L. Cope, M. Esser, A. Anderson, 2009, Clinical and Vaccine Immunology.